Cytocapsular Tube Networks for Directed Cell Transport

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for methods and compositions to understand cell locomotion in 3D extracellular matrices, as existing technologies fail to effectively elucidate the mechanisms of cell migration in such environments, which is crucial for various biological processes including embryo development, tissue regeneration, and disease management.

Innovation Solution

Cells implanted in a controlled 3D extracellular matrix generate novel membranous organelles called cytocapsulae and cytocapsular tubes, which form networks for directed cell transportation, facilitated by enhanced cap-dependent translation and increased expression of proteins like ITGB-2, providing tools for understanding cell migration mechanisms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If cells are studied in traditional 2D culture environments, then experimental simplicity and ease of observation are maintained, but the ability to understand cell locomotion in physiological 3D microenvironments is compromised

Engineering Contradiction:
Improveease of cell culture and observationVSAvoidaccuracy of cell migration mechanism understanding
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent transitions from traditional 2D cell culture surfaces to controlled 3D extracellular matrix environments, enabling cells to migrate and form cytocapsulae in three-dimensional space. This dimensional change allows observation of physiological cell behaviors that cannot be captured in planar cultures, directly addressing the limitation of 2D models in representing in vivo conditions.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The patent introduces controlled 3D extracellular matrix compositions as an intermediary system between cells and their natural physiological environment. This intermediate model provides a simplified yet physiologically relevant framework that enables study of cell migration mechanisms without requiring complex in vivo systems, thus bridging the gap between experimental simplicity and physiological accuracy.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If cells are implanted in controlled 3D extracellular matrices, then understanding of cell migration mechanisms in physiological environments is improved, but experimental complexity and difficulty of observation increase

Engineering Contradiction:
Improveaccuracy of cell migration mechanism understandingVSAvoidcomplexity of 3D matrix system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent employs controlled changes in extracellular matrix parameters including composition, porosity, stiffness, and degradation characteristics to modulate cell behavior. By systematically varying these parameters, the patent enables precise control over cell migration, cytocapsulae formation, and tube network development, allowing isolation and study of specific migration mechanisms while maintaining manageable experimental complexity.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates spatially heterogeneous 3D extracellular matrix environments with varying local properties such as density, composition, and structural features at different locations. This local quality variation enables cells to experience diverse microenvironmental cues that drive differentiated migration behaviors and organelle formation, providing mechanistic insights while maintaining overall system manageability through modular design.

Inventive Principle:
Principle #3Local quality

3Speed

If cytocapsular tube networks are formed for directed cell transportation, then cell migration efficiency and directionality are improved, but the complexity of cellular organelle formation and regulation increases

Engineering Contradiction:
Improvespeed of directed cell transportationVSAvoidcomplexity of organelle formation process
Core Design Contradiction:
SpeedVSDevice complexity

Solution Approach 1:

The patent demonstrates that cells autonomously generate cytocapsulae and assemble cytocapsular tube networks without external guidance or complex machinery. The cells self-organize these membranous structures through intrinsic signaling pathways and cytoskeletal dynamics, enabling directed transportation while avoiding the need for complex exogenous control systems or artificial scaffolds.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent identifies and utilizes preliminary cellular actions including cap-dependent translation enhancement and protein expression (such as ITGB-2) that occur before cytocapsular tube formation. These preparatory molecular events establish the cellular machinery and signaling states necessary for subsequent rapid tube assembly and directed cell migration, separating the formation process into discrete, studyable stages.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS11162069B2Methods for generation of cytocapsulae and cytocapsular tubes
Publication Date: 2021.11.02 CELLMIG BIOLABS INC
  • US11162069B2 patent drawing
  • US11162069B2 patent drawing
  • US11162069B2 patent drawing

AI summary

This invention provides for methods and compositions for generation of cytocapsulae and cytocapsular tubes in a 3D matrix.